RISALITI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 18.911
AS - Asia 7.602
EU - Europa 7.445
SA - Sud America 1.693
AF - Africa 136
Continente sconosciuto - Info sul continente non disponibili 34
OC - Oceania 6
Totale 35.827
Nazione #
US - Stati Uniti d'America 18.710
SG - Singapore 3.751
UA - Ucraina 1.913
CN - Cina 1.672
IT - Italia 1.574
DE - Germania 1.462
BR - Brasile 1.421
HK - Hong Kong 839
FI - Finlandia 683
VN - Vietnam 526
RU - Federazione Russa 488
FR - Francia 410
IE - Irlanda 322
SE - Svezia 192
GB - Regno Unito 164
TR - Turchia 157
IN - India 151
KR - Corea 133
CA - Canada 117
AR - Argentina 112
ID - Indonesia 61
BD - Bangladesh 59
IR - Iran 55
EC - Ecuador 47
MX - Messico 44
IQ - Iraq 34
PL - Polonia 34
ZA - Sudafrica 32
EU - Europa 29
PY - Paraguay 28
AT - Austria 27
ES - Italia 27
BE - Belgio 26
VE - Venezuela 25
CZ - Repubblica Ceca 23
PK - Pakistan 23
CO - Colombia 22
MA - Marocco 22
NL - Olanda 21
UZ - Uzbekistan 21
JP - Giappone 19
EG - Egitto 18
AE - Emirati Arabi Uniti 15
CL - Cile 14
KE - Kenya 14
KZ - Kazakistan 11
TN - Tunisia 11
UY - Uruguay 10
AL - Albania 9
DO - Repubblica Dominicana 9
PE - Perù 9
RO - Romania 9
BG - Bulgaria 8
NP - Nepal 8
CR - Costa Rica 7
DZ - Algeria 7
JO - Giordania 7
LT - Lituania 7
AO - Angola 6
AZ - Azerbaigian 6
CH - Svizzera 6
DK - Danimarca 6
EE - Estonia 6
HN - Honduras 6
SA - Arabia Saudita 6
SN - Senegal 6
TG - Togo 6
TW - Taiwan 6
AU - Australia 5
BH - Bahrain 5
LA - Repubblica Popolare Democratica del Laos 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BO - Bolivia 4
GT - Guatemala 4
KG - Kirghizistan 4
NO - Norvegia 4
XK - ???statistics.table.value.countryCode.XK??? 4
CI - Costa d'Avorio 3
CY - Cipro 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
LI - Liechtenstein 2
LV - Lettonia 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
Totale 35.805
Città #
Fairfield 2.212
Woodbridge 1.540
Jacksonville 1.393
Ashburn 1.358
Singapore 1.261
Houston 1.098
Chandler 1.025
Wilmington 979
Ann Arbor 925
Dearborn 907
Beijing 881
Hong Kong 835
Seattle 825
Cambridge 795
Boardman 393
Princeton 352
Udine 346
Dublin 320
Los Angeles 317
Dallas 205
Ho Chi Minh City 179
Munich 175
Hefei 172
Chicago 162
Buffalo 146
Izmir 131
Seoul 126
Hanoi 121
São Paulo 121
San Diego 119
Redondo Beach 86
New York 82
Helsinki 80
Salt Lake City 75
Ogden 66
Mumbai 63
Norwalk 62
Milan 59
Rio de Janeiro 56
Rome 53
Ottawa 52
Dong Ket 48
Nanjing 48
Des Moines 47
Kunming 46
Elk Grove Village 45
Augusta 37
Tampa 34
Monmouth Junction 32
Turku 31
Leawood 29
Washington 28
Shanghai 27
Bologna 26
Düsseldorf 26
Porto Alegre 26
Toronto 26
Brussels 25
Guangzhou 25
Brooklyn 24
Frankfurt am Main 24
Warsaw 24
Belo Horizonte 23
Curitiba 23
Nanchang 23
Phoenix 23
Jinan 22
Sterling 22
Stockholm 22
Redmond 21
San Mateo 21
Ardabil 19
Brasília 19
Haiphong 19
London 19
Nuremberg 19
Tashkent 19
Brno 18
Denver 18
Florence 18
Fuzhou 18
Santa Clara 18
Lancaster 17
Montreal 17
Poplar 17
Quito 17
Tokyo 17
Trieste 17
Campinas 16
San Francisco 16
Simi Valley 16
The Dalles 16
Chennai 15
Hải Dương 15
Pune 15
Santo André 15
Zanjan 15
Guayaquil 14
Miami 14
Orem 14
Totale 21.518
Nome #
Breast Cancer Oncological Outcomes at an Italian Center Following Nipple-Sparing and Skin-Sparing Mastectomy Techniques 428
L’ANASTOMOSI DI SALVATAGGIO CAVO-CAVALE INFRAEPATICA NEL TRAPIANO DI FEGATO CON TECNICA PIGGY-BACK 395
L’ANASTOMOSI DI SALVATAGGIO CAVO-CAVALE INFRAEPATICA NEL TRAPIANTO DI FEGATO CON TECNICA PIGGY-BACK 373
Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery 324
A Particular Use of Endobag®: Extraction of Rectal Foreign Bodies 274
Extended Ureteral Stricture Corrected with Appendiceal Replacement in a Kidney Transplant Recipient 268
LA DERIVAZIONE SPLENO-RENALE SCONDO WARREN NELLA CIRROSI ALCOLICA: VALIDITA' DI ALCUNI ACCORGIMENTI TECNICI 238
Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study 232
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 229
A single-center experience of late retransplantation of the liver. 209
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 205
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 205
GLI ACE-INIBITORI CORREGGONO LA ERITROCITOSI POST-TRAPIANTO RENALE MEDIANTE MECCANISMI ERITROPOIETINO-INDIPENDENTI 203
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 191
Abdominal cross-sectional imaging of the associating liver partition and portal vein ligation for staged hepatectomy procedure 188
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 186
Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. 186
Microscopic peritoneal carcinomatosis in gastric cancer: Prevalence, prognosis and predictive factors 185
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation 181
Long term results of hepatic resection or orthotopic liver transplantation in patients with liver metastases from gastrointestinal neuroendocrine tumors 181
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 181
TERAPIA A LUNGO TERMINE DELLA ERITROCITOSI POST-TRAPIANTO RENALE CON ACE-INIBITORI: EFFICACIA, SICUREZZA, E MECANISMI D’AZIONE 179
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 179
CANCRO DEL COLON-RETTO. CONFRONTO FRA STAGING, GRADING E POSITIVITA' DI ALCUNI TUMOR MARKERS 177
Liver transplantation from old donors into HCV and non-HCV recipients 172
Liver transplantation in neurological Wilson's disease: Is there indication? a case report 172
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 172
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 167
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 166
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 164
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 164
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 162
Single-time kidney transplantation and monolateral nephrectomy for hypertension and antihypertensive therapy in renal transplant recipients 162
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 161
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 161
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 160
Arterial rupture as the result of fungal arteritis after renal transplantation 157
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 157
Macrocystic serous cystadenoma of the pancreas: Report of 4 cases 157
Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography 157
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 154
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 154
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 153
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 153
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 152
Acute pancreatitis after kidney transplantation. 151
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 151
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 151
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 150
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 149
Quality-of-life assessment before and after liver transplantation. 149
Resected biliary tract cancers: A novel clinical-pathological score correlates with global outcome 149
Donor safety in living donor liver donation: An Italian multicenter survey 149
Adult-to-adult living donor liver transplantation using left lobes: the importance of surgical modulations on portal graft inflow. 148
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 148
Type of breast cancer diagnosis, screening, and survival 148
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 147
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 146
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: A large retrospective cross-sectional study 146
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 146
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 145
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 144
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 144
Future of minimally invasive surgery 143
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 143
ELDERLY VERSUS YOUNG LIVER TRANSPLANT RECIPIENTS: PATIENT AND GRAFT SURVIVAL. 141
Surgical and oncological outcomes of free dermal fat graft for breast reconstruction after breast-conserving surgery 141
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 140
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. 139
Transarterial chemoembolization does not harm the hepatic artery at transplantation 139
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 139
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 138
Spontaneous portal vein arterialization in hepatic artery thrombosis 137
Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies 137
Graft vessel wall pathology in a case of hepatic artery pseudo-aneurysm in a liver transplant recipient 137
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 137
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 137
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 136
Appendicectomy and Crohn's disease: clinical and genetic associations 135
A national mandatory-split liver policy: A report from the Italian experience 135
Hepatic portal venous gas in a patient with enterovascular fistula. 134
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 133
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 133
RENAL TRANSPLANTATION IN A PATIENT AFFECTED BY MOUNIER-KUHN SYNDROME 132
Liver Retransplantation in Adults: The Largest Multicenter Italian Study 132
UN NUOVO APPROCCIO NEL TRATTAMENTO LAPAROSCOPICO DEL LINFOCELE DOPO IL TRAPIANTO DI RENE 131
Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update 131
Breast reconstruction with acellular dermal matrix: a brief analysis of costs 131
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 130
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 130
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 129
Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis 129
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 127
Right lobe living related graft loss due to intrahepatic multiple arterio-portal fistulas. 127
Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery. 127
Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection 126
GRAFT VESSEL WALL PATHOLOGY IN A CASE OF HEPATIC ARTERY PSEUDO-ANEURYSM IN A LIVER TRANSPLANT RECIPIENT. 126
Early post-liver transplant surgical morbidity in HIV infected recipients: risk factor for overall survival? A nationwide retrospective study 126
Chronological changes in skeletal muscle mass following living-donor liver transplantation: An analysis of the predictive factors for long-term post-transplant low muscularity 125
Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications 124
Totale 16.572
Categoria #
all - tutte 133.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.783 0 0 0 0 0 474 232 515 672 147 560 183
2021/20222.527 104 335 62 102 29 88 117 124 27 491 614 434
2022/20232.530 397 172 44 301 208 690 21 178 332 47 76 64
2023/2024786 106 67 27 20 142 117 13 55 133 47 8 51
2024/20256.066 189 414 193 165 214 322 315 315 598 490 1.008 1.843
2025/20266.418 729 1.710 1.079 1.215 1.520 165 0 0 0 0 0 0
Totale 36.222